Detection of amyloid beta aggregates in the brain of BALB/c mice after Chlamydia pneumoniae infection
Open accessAbstract
Neuroinflammation, initiated by cerebral infection, is increasingly postulated as an aetiological factor in neurodegenerative diseases such as Alzheimer's disease (AD). We investigated whether Chlamydia pneumoniae (Cpn) infection results in extracellular aggregation of amyloid beta (Abeta) in BALB/c mice. At 1 week post intranasal infection (p.i.), Cpn DNA was detected predominantly in the olfactory bulbs by PCR, whereas brains at 1 and 3 months p.i. were Cpn negative. At 1 and 3 months p.i., extracellular Abeta immunoreactivity was detected in the brain of Cpn-infected mice but also in the brain of mock-infected mice and mice that were neither Cpn infected nor mock infected. However, these extracellular Abeta aggregates showed morphological differences compared to extracellular Abeta aggregates detected in the brain of transgenic APP751(SL)/PS1(M146L) mice. These data do not unequivocally support the hypothesis that Cpn infection induces the formation of AD-like Abeta plaques in the brain of BALB/c mice, as suggested before. However, future studies are required to resolve these differences and to investigate whether Cpn is indeed an etiological factor in AD pathogenesis.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
C. pneumoniae DNA in the olfactory mucosa and olfactory bulb has been detected 1 week after inoculation.
“After intranasal inoculation in mice, C. pneumoniae antigens and/or infectious organisms have been detected in the olfactory mucosa and the olfactory bulb 1–4 months post intranasal inoculation16–18, and C. pneumoniae DNA in these tissues has been detected 1 week after inoculation18, strongly suggesting that the bacteria can infect the CNS via the olfactory nerve.”
From Chlamydia pneumoniae can infect the central nervous system via the olfactory and trigeminal nerves and contributes to Alzheimer’s disease risk (2022) · cites this paper as [18]
The Results section reports C. pneumoniae DNA in the olfactory bulbs of infected mice one week after inoculation. The Methods section lists the brain regions tested but does not include the olfactory mucosa, so this source does not support the claim of detection in both tissues. (LLM, conf=0.88)
Experimental — accuracy not yet measuredC. pneumoniae DNA, antigen and/or live bacteria have been detected in the brain of inoculated mice, which resulted in Aβ deposition or altered appearance of Aβ deposits.
“C. pneumoniae DNA, antigen and/or live bacteria have been detected in the brain of inoculated mice15–18, which resulted in Aβ deposition16,17 or altered appearance of Aβ deposits18.”
From Chlamydia pneumoniae can infect the central nervous system via the olfactory and trigeminal nerves and contributes to Alzheimer’s disease risk (2022) · cites this paper as [18]
The Discussion reports C. pneumoniae DNA in the olfactory bulbs of infected mice one week after inoculation. But it reports nearly identical Aβ immunoreactivity in infected, mock-infected, and uninoculated BALB/c mice, suggesting that the deposits did not directly result from infection. The morphological differences described in the Results are between BALB/c and transgenic mice, not between infected and uninfected BALB/c mice. (LLM, conf=0.88)
Experimental — accuracy not yet measuredAfter intranasal inoculation in mice, C. pneumoniae antigens and/or infectious organisms have been detected in the olfactory mucosa and the olfactory bulb 1-4 months post intranasal inoculation.
“After intranasal inoculation in mice, C. pneumoniae antigens and/or infectious organisms have been detected in the olfactory mucosa and the olfactory bulb 1–4 months post intranasal inoculation16–18, and C. pneumoniae DNA in these tissues has been detected 1 week after inoculation18, strongly suggesting that the bacteria can infect the CNS via the olfactory nerve.”
From Chlamydia pneumoniae can infect the central nervous system via the olfactory and trigeminal nerves and contributes to Alzheimer’s disease risk (2022) · cites this paper as [18]
The Discussion (page unavailable) reports that Little et al. detected C. pneumoniae in infected mice’s olfactory tissues up to 3 months after inoculation. This paper’s own Results found C. pneumoniae DNA in the olfactory bulb at 1 week, but not at 1 or 3 months; it does not establish detection of antigens or infectious organisms in both named tissues at 1–4 months. (LLM, conf=0.86)
Experimental — accuracy not yet measuredThe mice used in these studies were wild-type mice and not mouse models of Alzheimer's disease, suggesting that C. pneumoniae can contribute to the neuropathologies associated with late-onset dementia.
“Importantly, the mice used in these studies were wild-type mice and not mouse models of Alzheimer’s disease, suggesting that C. pneumoniae can contribute to the neuropathologies associated with late-onset dementia.”
From Chlamydia pneumoniae can infect the central nervous system via the olfactory and trigeminal nerves and contributes to Alzheimer’s disease risk (2022) · cites this paper as [18]
The Discussion identifies the infected BALB/c mice as naïve, non-transgenic mice, supporting the wild-type part of the claim. But it reports similar Aβ immunoreactivity in infected and uninfected mice and concludes that the data do not unequivocally support infection-induced AD-like plaques. The proposed contribution to late-onset dementia remains a possibility, not a finding established by this study. (LLM, conf=0.88)
Experimental — accuracy not yet measuredPrevious studies have shown that Aβ accumulation after C. pneumoniae inoculation occurs after months.
“Whilst previous studies have shown that this occurs after months16–18, if the bacteria reach the CNS more rapidly, alterations in Aβ deposition may also occur sooner.”
From Chlamydia pneumoniae can infect the central nervous system via the olfactory and trigeminal nerves and contributes to Alzheimer’s disease risk (2022) · cites this paper as [18]
The Results summarized in the paper report extracellular Aβ immunoreactivity at 1 and 3 months after C. pneumoniae inoculation. However, the Discussion says similar immunoreactivity occurred in mock-infected and untreated mice, so this study does not establish that inoculation caused Aβ accumulation. (LLM, conf=0.87)
Experimental — accuracy not yet measured
Control uninfected mice exhibited diffuse Aβ deposits.
“while control uninfected mice exhibited diffuse Aβ deposits (Fig. 5P) which is similar to previous reports16,18,50.”
From Chlamydia pneumoniae can infect the central nervous system via the olfactory and trigeminal nerves and contributes to Alzheimer’s disease risk (2022) · cites this paper as [18]
The faster time-frame may be due to differences in inoculation dose since they used a higher dose than two previous studies but lower than another.
“which may be due to differences in the inoculation dose since we used a higher inoculation dose than two previous studies16,50 but lower than another18.”
From Chlamydia pneumoniae can infect the central nervous system via the olfactory and trigeminal nerves and contributes to Alzheimer’s disease risk (2022) · cites this paper as [18]
The time-frame for infection of the CNS by C. pneumoniae was considerably faster than what has previously been shown (1 week-3 months).
“The time-frame for infection of the CNS by C. pneumoniae was considerably faster than what has previously been shown (1 week–3 months16–18)”
From Chlamydia pneumoniae can infect the central nervous system via the olfactory and trigeminal nerves and contributes to Alzheimer’s disease risk (2022) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
No references could be resolved yet.
Research works printed but not linked: 33
- [1]Balin BJ Appelt DM Role of infection in Alzheimer’s disease J Am Osteopath Assoc 2001 101 S1 S6 11794745 Balin BJ, Appelt DM (2001) Role of infection in Alzheimer’s disease. J Am Osteopath Assoc 101:S1–S6 11794745
- [2]Balin BJ Gerard HC Arking EJ Appelt DM Branigan PJ Abrams JT Whittum-Hudson JA Hudson AP Identification and localization of Chlamydia pneumoniae in the Alzheimer’s brain Med Microbiol Immunol (Berl) 1998 187 23 42 10.1007/s004300050071 9749980 Balin BJ, Gerard HC, Arking EJ, Appelt DM, Branigan PJ, Abrams JT, Whittum-Hudson JA, Hudson AP (1998) Identification and localization of Chlamydia pneumoniae in the Alzheimer’s brain. Med Microbiol Immunol (Berl) 187:23–42 9749980 · DOI · Paper page
- [3]Bhatia R Lin H Lal R Fresh and globular amyloid beta protein (1–42) induces rapid cellular degeneration: evidence for AbetaP channel-mediated cellular toxicity FASEB J 2000 14 1233 1243 10834945 Bhatia R, Lin H, Lal R (2000) Fresh and globular amyloid beta protein (1–42) induces rapid cellular degeneration: evidence for AbetaP channel-mediated cellular toxicity. FASEB J 14:1233–1243 10834945
- [4]Blanchard V Moussaoui S Czech C Touchet N Bonici B Planche M Canton T Jedidi I Gohin M Wirths O Bayer TA Langui D Duyckaerts C Tremp G Pradier L Time sequence of maturation of dystrophic neurites associated with Abeta deposits in APP/PS1 transgenic mice Exp Neurol 2003 184 247 263 10.1016/S0014-4886(03)00252-8 14637096 Blanchard V, Moussaoui S, Czech C, Touchet N, Bonici B, Planche M, Canton T, Jedidi I, Gohin M, Wirths O, Bayer TA, Langui D, Duyckaerts C, Tremp G, Pradier L (2003) Time sequence of maturation of dystrophic neurites associated with Abeta deposits in APP/PS1 transgenic mice. Exp Neurol 184:247–263 14637096 · DOI · Paper page
- [5]Boelen E Steinbusch HW van der Ven AJ Grauls G Bruggeman CA Stassen FR Chlamydia pneumoniae infection of brain cells: an in vitro study Neurobiol Aging 2007 28 4 524 532 10.1016/j.neurobiolaging.2006.02.014 16621171 Boelen E, Steinbusch HW, van der Ven AJ, Grauls G, Bruggeman CA, Stassen FR (2007) Chlamydia pneumoniae infection of brain cells: an in vitro study. Neurobiol Aging 28(4):524–532 16621171 · DOI
- [6]Dobson CB Itzhaki RF Herpes simplex virus type 1 and Alzheimer’s disease Neurobiol Aging 1999 20 457 465 10.1016/S0197-4580(99)00055-X 10604441 Dobson CB, Itzhaki RF (1999) Herpes simplex virus type 1 and Alzheimer’s disease. Neurobiol Aging 20:457–465 10604441 · DOI
- [7]Ezzahiri R Stassen FR Kurvers HA Pul MM Kitslaar PJ Bruggeman CA Chlamydia pneumoniae infection induces an unstable atherosclerotic plaque phenotype in LDL-receptor, ApoE double knockout mice Eur J Vasc Endovasc Surg 2003 26 88 95 10.1053/ejvs.2002.1913 12819654 Ezzahiri R, Stassen FR, Kurvers HA, van Pul MM, Kitslaar PJ, Bruggeman CA (2003) Chlamydia pneumoniae infection induces an unstable atherosclerotic plaque phenotype in LDL-receptor, ApoE double knockout mice. Eur J Vasc Endovasc Surg 26:88–95 12819654 · DOI
- [8]Gerard HC Dreses-Werringloer U Wildt KS Deka S Oszust C Balin BJ Frey WH Bordayo EZ Whittum-Hudson JA Hudson AP Chlamydophila (Chlamydia) pneumoniae in the Alzheimer’s brain FEMS Immunol Med Microbiol 2006 48 355 366 10.1111/j.1574-695X.2006.00154.x 17052268 Gerard HC, Dreses-Werringloer U, Wildt KS, Deka S, Oszust C, Balin BJ, Frey WH II, Bordayo EZ, Whittum-Hudson JA, Hudson AP (2006) Chlamydophila (Chlamydia) pneumoniae in the Alzheimer’s brain. FEMS Immunol Med Microbiol 48:355–366 17052268 · DOI · Paper page
- [9]Gieffers J Reusche E Solbach W Maass M Failure to detect Chlamydia pneumoniae in brain sections of Alzheimer’s disease patients J Clin Microbiol 2000 38 881 882 PMC86233 10655406 Gieffers J, Reusche E, Solbach W, Maass M (2000) Failure to detect Chlamydia pneumoniae in brain sections of Alzheimer’s disease patients. J Clin Microbiol 38:881–882 10655406 PMC86233
- [10]Grayston JT Campbell LA Kuo CC Mordhorst CH Saikku P Thom DH Wang SP A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR J Infect Dis 1990 161 618 625 2181028 Grayston JT, Campbell LA, Kuo CC, Mordhorst CH, Saikku P, Thom DH, Wang SP (1990) A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis 161:618–625 2181028
- [11]Grayston JT Aldous MB Easton A Wang SP Kuo CC Campbell LA Altman J Evidence that Chlamydia pneumoniae causes pneumonia and bronchitis J Infect Dis 1993 168 1231 1235 8228356 Grayston JT, Aldous MB, Easton A, Wang SP, Kuo CC, Campbell LA, Altman J (1993) Evidence that Chlamydia pneumoniae causes pneumonia and bronchitis. J Infect Dis 168:1231–1235 8228356
- [12]Hemling N Roytta M Rinne J Pollanen P Broberg E Tapio V Vahlberg T Hukkanen V Herpesviruses in brains in Alzheimer’s and Parkinson’s diseases Ann Neurol 2003 54 267 271 10.1002/ana.10662 12891684 Hemling N, Roytta M, Rinne J, Pollanen P, Broberg E, Tapio V, Vahlberg T, Hukkanen V (2003) Herpesviruses in brains in Alzheimer’s and Parkinson’s diseases. Ann Neurol 54:267–271 12891684 · DOI
- [13]Kolson DL Gonzalez-Scarano F HIV and HIV dementia J Clin Invest 2000 106 11 13 PMC314369 10880043 Kolson DL, Gonzalez-Scarano F (2000) HIV and HIV dementia. J Clin Invest 106:11–13 10880043 PMC314369
- [14]Kuo CC Grayston JT Campbell LA Goo YA Wissler RW Benditt EP Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15–34 years old) Proc Natl Acad Sci USA 1995 92 6911 6914 10.1073/pnas.92.15.6911 PMC41440 7624342 Kuo CC, Grayston JT, Campbell LA, Goo YA, Wissler RW, Benditt EP (1995) Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15–34 years old). Proc Natl Acad Sci USA 92:6911–6914 7624342 PMC41440 · DOI
- [15]Kuo CC Jackson LA Campbell LA Grayston JT Chlamydia pneumoniae (TWAR) Clin Microbiol Rev 1995 8 451 461 PMC172870 8665464 Kuo CC, Jackson LA, Campbell LA, Grayston JT (1995) Chlamydia pneumoniae (TWAR). Clin Microbiol Rev 8:451–461 8665464 PMC172870
- [16]Law A Gauthier S Quirion R Say NO to Alzheimer’s disease: the putative links between nitric oxide and dementia of the Alzheimer’s type Brain Res Brain Res Rev 2001 35 73 96 10.1016/S0165-0173(00)00051-5 11245887 Law A, Gauthier S, Quirion R (2001) Say NO to Alzheimer’s disease: the putative links between nitric oxide and dementia of the Alzheimer’s type. Brain Res Brain Res Rev 35:73–96 11245887 · DOI
- [17]Lin WR Wozniak MA Cooper RJ Wilcock GK Itzhaki RF Herpesviruses in brain and Alzheimer’s disease J Pathol 2002 197 395 402 10.1002/path.1127 12115887 Lin WR, Wozniak MA, Cooper RJ, Wilcock GK, Itzhaki RF (2002) Herpesviruses in brain and Alzheimer’s disease. J Pathol 197:395–402 12115887 · DOI
- [18]Lippa CF Saunders AM Smith TW Swearer JM Drachman DA Ghetti B Nee L Pulaski-Salo D Dickson D Robitaille Y Bergeron C Crain B Benson MD Farlow M Hyman BT George-Hyslop SP Roses AD Pollen DA Familial and sporadic Alzheimer’s disease: neuropathology cannot exclude a final common pathway Neurology 1996 46 406 412 8614503 Lippa CF, Saunders AM, Smith TW, Swearer JM, Drachman DA, Ghetti B, Nee L, Pulaski-Salo D, Dickson D, Robitaille Y, Bergeron C, Crain B, Benson MD, Farlow M, Hyman BT, George-Hyslop SP, Roses AD, Pollen DA (1996) Familial and sporadic Alzheimer’s disease: neuropathology cannot exclude a final common pathway. Neurology 46:406–412 8614503
- [19]Little CS Hammond CJ MacIntyre A Balin BJ Appelt DM Chlamydia pneumoniae induces Alzheimer-like amyloid plaques in brains of BALB/c mice Neurobiol Aging 2004 25 419 429 10.1016/S0197-4580(03)00127-1 15013562 Little CS, Hammond CJ, MacIntyre A, Balin BJ, Appelt DM (2004) Chlamydia pneumoniae induces Alzheimer-like amyloid plaques in brains of BALB/c mice. Neurobiol Aging 25:419–429 15013562 · DOI · Paper page
- [20]MacDonald AB Plaques of Alzheimer’s disease originate from cysts of Borrelia burgdorferi, the Lyme disease spirochete Med Hypotheses 2006 67 592 600 10.1016/j.mehy.2006.02.035 16675154 MacDonald AB (2006) Plaques of Alzheimer’s disease originate from cysts of Borrelia burgdorferi, the Lyme disease spirochete. Med Hypotheses 67:592–600 16675154 · DOI
- [21]Mattson MP Infectious agents and age-related neurodegenerative disorders Ageing Res Rev 2004 3 105 120 10.1016/j.arr.2003.08.005 PMC7172323 15163105 Mattson MP (2004) Infectious agents and age-related neurodegenerative disorders. Ageing Res Rev 3:105–120 15163105 PMC7172323 · DOI
- [22]Nochlin D Shaw CM Campbell LA Kuo CC Failure to detect Chlamydia pneumoniae in brain tissues of Alzheimer’s disease Neurology 1999 53 1888 10563652 Nochlin D, Shaw CM, Campbell LA, Kuo CC (1999) Failure to detect Chlamydia pneumoniae in brain tissues of Alzheimer’s disease. Neurology 53:1888 10563652
- [23]Ring RH Lyons JM Failure to detect Chlamydia pneumoniae in the late-onset Alzheimer’s brain J Clin Microbiol 2000 38 2591 2594 PMC86976 10878049 Ring RH, Lyons JM (2000) Failure to detect Chlamydia pneumoniae in the late-onset Alzheimer’s brain. J Clin Microbiol 38:2591–2594 10878049 PMC86976
- [24]Robertson M Is Chlamydia associated with Alzheimer’s? Drug Discov Today 2004 9 469 10.1016/S1359-6446(04)03124-1 15149617 Robertson M (2004) Is Chlamydia associated with Alzheimer’s? Drug Discov Today 9:469 15149617 · DOI
- [25]Roblin PM Dumornay W Hammerschlag MR Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniae J Clin Microbiol 1992 30 1968 1971 PMC265424 1500500 Roblin PM, Dumornay W, Hammerschlag MR (1992) Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniae. J Clin Microbiol 30:1968–1971 1500500 PMC265424
- [26]Schmitz C Rutten BP Pielen A Schafer S Wirths O Tremp G Czech C Blanchard V Multhaup G Rezaie P Korr H Steinbusch HW Pradier L Bayer TA Hippocampal neuron loss exceeds amyloid plaque load in a transgenic mouse model of Alzheimer’s disease Am J Pathol 2004 164 1495 1502 PMC1615337 15039236 Schmitz C, Rutten BP, Pielen A, Schafer S, Wirths O, Tremp G, Czech C, Blanchard V, Multhaup G, Rezaie P, Korr H, Steinbusch HW, Pradier L, Bayer TA (2004) Hippocampal neuron loss exceeds amyloid plaque load in a transgenic mouse model of Alzheimer’s disease. Am J Pathol 164:1495–1502 15039236 PMC1615337
- [27]Tanzi RE Kovacs DM Kim TW Moir RD Guenette SY Wasco W The gene defects responsible for familial Alzheimer’s disease Neurobiol Dis 1996 3 159 168 10.1006/nbdi.1996.0016 8980016 Tanzi RE, Kovacs DM, Kim TW, Moir RD, Guenette SY, Wasco W (1996) The gene defects responsible for familial Alzheimer’s disease. Neurobiol Dis 3:159–168 8980016 · DOI · Paper page
- [28]Taylor GS Vipond IB Paul ID Matthews S Wilcock GK Caul EO Failure to correlate C. pneumoniae with late onset Alzheimer’s disease Neurology 2002 59 142 143 12105327 Taylor GS, Vipond IB, Paul ID, Matthews S, Wilcock GK, Caul EO (2002) Failure to correlate C. pneumoniae with late onset Alzheimer’s disease. Neurology 59:142–143 12105327
- [29]Tondella ML Talkington DF Holloway BP Dowell SF Cowley K Soriano-Gabarro M Elkind MS Fields BS Development and evaluation of real-time PCR-based fluorescence assays for detection of Chlamydia pneumoniae J Clin Microbiol 2002 40 575 583 10.1128/JCM.40.2.575-583.2002 PMC153405 11825973 Tondella ML, Talkington DF, Holloway BP, Dowell SF, Cowley K, Soriano-Gabarro M, Elkind MS, Fields BS (2002) Development and evaluation of real-time PCR-based fluorescence assays for detection of Chlamydia pneumoniae. J Clin Microbiol 40:575–583 11825973 PMC153405 · DOI
- [30]Weinberger M Respiratory infections and asthma: current treatment strategies Drug Discov Today 2004 9 831 837 10.1016/S1359-6446(04)03239-8 15381135 Weinberger M (2004) Respiratory infections and asthma: current treatment strategies. Drug Discov Today 9:831–837 15381135 · DOI
- [31]Wucherpfennig KW Infectious triggers for inflammatory neurological diseases Nat Med 2002 8 455 457 10.1038/nm0502-455 11984586 Wucherpfennig KW (2002) Infectious triggers for inflammatory neurological diseases. Nat Med 8:455–457 11984586 · DOI
- [32]Yucesan C Sriram S Chlamydia pneumoniae infection of the central nervous system Curr Opin Neurol 2001 14 355 359 10.1097/00019052-200106000-00015 11371760 Yucesan C, Sriram S (2001) Chlamydia pneumoniae infection of the central nervous system. Curr Opin Neurol 14:355–359 11371760 · DOI
- [33]Zhu YJ Lin H Lal R Fresh and nonfibrillar amyloid beta protein (1–40) induces rapid cellular degeneration in aged human fibroblasts: evidence for AbetaP-channel-mediated cellular toxicity FASEB J 2000 14 1244 1254 10834946 Zhu YJ, Lin H, Lal R (2000) Fresh and nonfibrillar amyloid beta protein (1–40) induces rapid cellular degeneration in aged human fibroblasts: evidence for AbetaP-channel-mediated cellular toxicity. FASEB J 14:1244–1254 10834946
Cited by
Sorted by citations
Kumar, D. K. V., Choi, S. H., Washicosky, K. J., Eimer, W. A., Tucker, S., Ghofrani, J., Lefkowitz, A., McColl, G., Goldstein, L. E., Tanzi, R. E., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf1059 · Cited by 971 · see citing works
The Physiological Roles of Amyloid-β Peptide Hint at New Ways to Treat Alzheimer's Disease
Brothers, H. M., Gosztyla, M. L., & Robinson, S. R. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00118 · Cited by 314 · see citing works
The gut microbiome in Alzheimer’s disease: what we know and what remains to be explored
Chandra, S., Sisodia, S. S., & Vassar, R. J. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00595-7 · Cited by 278 · see citing works
Chacko, A., Delbaz, A., Walkden, H., Basu, S., Armitage, C. W., Eindorf, T., Trim, L. K., Miller, E., West, N. P., St John, J. A., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-06749-9 · Cited by 65 · see citing works
- Authors
- Boelen, E., Stassen, F. R. M., van der Ven, A. J. A. M., Lemmens, M. A. M., Steinbusch, H. P. J., Bruggeman, C. A., Schmitz, C., & Steinbusch, H. W. M.
- Affiliations
- Maastricht University (NL)
- Corresponding author
- Boelen, Ellen
- Venue
- Acta Neuropathologica
- Published
- 2007-06-21
- Volume
- 114
- Issue
- 3
- Pages
- 255-261
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- PMC
- PMC2039821
- OpenAlex
- W2051201119
- Cited by
- 41
- References
- 0
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 1 · 2023: 2 · 2022: 1 · 2021: 6 · 2020: 5 · 2019: 2 · 2018: 4 · 2017: 1 · 2016: 3 · 2015: 1 · 2014: 2 · 2013: 1
- FWCI
- 0.63
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Acta Neuropathologica (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- Internationale Stichting Alzheimer Onderzoek
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Chlamydia pneumoniae, amyloid-beta, Alzheimer's disease, neuroinflammation, neurodegeneration, bacterial infection, olfactory bulb, APP/PS1 mice, BALB/c mice, amyloid plaques
- MeSH terms
- Animals, Brain, Female, Humans, Immunohistochemistry, Mice, Inbred BALB C, Mice, Transgenic, Peptide Fragments, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Chlamydophila pneumoniae, Microscopy, Confocal, Neurodegenerative Diseases, Reverse Transcriptase Polymerase Chain Reaction, Chlamydophila Infections, Mice, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review